Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)

Y. Y. Elamin; M. Antonoff; C. Blakely; M. Baggstorm; T. Bivona; X. Le; A. V. Louie; R. C. Doebele; C. Rusthoven; P. Lee; R. Govindan; S. G. Swisher; V. A. Papadimitrakopoulou; J. V. Heymach; D. R. Gomez

doi:10.1093/annonc/mdy292.130

Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)

Y. Y. Elamin, M. Antonoff, C. Blakely, M. Baggstorm, T. Bivona, X. Le, A. V. Louie, R. C. Doebele, C. Rusthoven, P. Lee, R. Govindan, S. G. Swisher, V. A. Papadimitrakopoulou, J. V. Heymach, D. R. Gomez

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	viii547
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy292.130
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy292.130

Cite this

Elamin, Y. Y., Antonoff, M., Blakely, C., Baggstorm, M., Bivona, T., Le, X., Louie, A. V., Doebele, R. C., Rusthoven, C., Lee, P., Govindan, R., Swisher, S. G., Papadimitrakopoulou, V. A., Heymach, J. V., & Gomez, D. R. (2018). Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii547. https://doi.org/10.1093/annonc/mdy292.130

Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR). / Elamin, Y. Y.; Antonoff, M.; Blakely, C. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii547.

Research output: Contribution to journal › Article › peer-review

Elamin, YY , Antonoff, M, Blakely, C, Baggstorm, M, Bivona, T, Le, X, Louie, AV, Doebele, RC, Rusthoven, C, Lee, P, Govindan, R, Swisher, SG, Papadimitrakopoulou, VA, Heymach, JV & Gomez, DR 2018, 'Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii547. https://doi.org/10.1093/annonc/mdy292.130

@article{fabcf938973345738206148d7df11b53,

title = "Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)",

author = "Elamin, {Y. Y.} and M. Antonoff and C. Blakely and M. Baggstorm and T. Bivona and X. Le and Louie, {A. V.} and Doebele, {R. C.} and C. Rusthoven and P. Lee and R. Govindan and Swisher, {S. G.} and Papadimitrakopoulou, {V. A.} and Heymach, {J. V.} and Gomez, {D. R.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy292.130",

language = "English (US)",

volume = "29",

pages = "viii547",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)

AU - Elamin, Y. Y.

AU - Antonoff, M.

AU - Blakely, C.

AU - Baggstorm, M.

AU - Bivona, T.

AU - Le, X.

AU - Louie, A. V.

AU - Doebele, R. C.

AU - Rusthoven, C.

AU - Lee, P.

AU - Govindan, R.

AU - Swisher, S. G.

AU - Papadimitrakopoulou, V. A.

AU - Heymach, J. V.

AU - Gomez, D. R.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85076331524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076331524&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy292.130

DO - 10.1093/annonc/mdy292.130

M3 - Article

C2 - 32137425

SN - 0923-7534

VL - 29

SP - viii547

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this